DES reduce risk of repeat procedures without increasing risk of adverse events

Results of an observational study published in JAMA have shown that following the introduction of drug-eluting stents, repeat revascularisation rates have significantly decreased, and that their use is not associated with any adverse outcomes such as STEMI or death....